You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 255 No. 4, January 24, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (171)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acute Esophageal Variceal Sclerotherapy

Results of a Prospective Randomized Controlled Trial

Alan W. Larson, MD; Hartley Cohen, MD; Bruce Zweiban, MD; David Chapman, MD; Maurice Gourdji, MD; Jacob Korula, MD; John Weiner, DrPH

JAMA. 1986;255(4):497-500.


Abstract

Within 48 hours of variceal hemorrhage, 82 patients were randomly assigned to conventional treatment including balloon tamponade or to conventional treatment supplemented by sclerotherapy. The prerandomization general clinical characteristics of the two groups were similar. Seventy-nine percent of patients were alcoholic and 57% were in Child's class C. In the sclerotherapy group of 44 patients, sclerotherapy was performed twice in 28 patients and thrice in 13 patients over the two weeks of follow-up. The number of patients who rebled was significantly lower in the sclerotherapy group than in the group treated conventionally (23% vs 53%). The number of bleeding episodes also was significantly lower in the sclerotherapy group (15 vs 32). Moreover, blood transfusion requirements were significantly decreased in the sclerotherapy group. This was true even for patients who were bleeding at the time of randomization or who were in Child's class C, but this primarily was because fewer patients who underwent sclerotherapy (10 of 24 vs 18 of 23) required transfusions. Although there was no difference in survival between the two groups, we conclude that sclerotherapy is better than conventional treatment in the acute management of variceal bleeding.

(JAMA 1986;255:497-500)



Author Affiliations

From the Sections of Gastroenterology and Hepatology, Department of Medicine, University of Southern California School of Medicine, Los Angeles.


Footnotes

Reprint requests to Gastroenterology Section, Department of Medicine, University of Southern California School of Medicine, 2025 Zonal Ave, Los Angeles, CA 90033 (Dr Cohen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

UK guidelines on the management of variceal haemorrhage in cirrhotic patients
Jalan and Hayes
Gut 2000;46:iii1-15.
FULL TEXT  

Multipolar Electrocoagulation in the Treatment of Peptic Ulcers with Nonbleeding Visible Vessels: A Prospective, Controlled Trial
Laine
ANN INTERN MED 1989;110:510-514.
ABSTRACT  

Effect of Esophageal Variceal Sclerotherapy (EVS) on Lung Function: A Prospective Controlled Study
Korula et al.
Arch Intern Med 1986;146:1517-1520.
ABSTRACT  

Drug Therapy for Portal Hypertension
RECTOR
ANN INTERN MED 1986;105:96-107.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.